Hims & Hers to offer unapproved peptides to customers
Telehealth firm Hims & Hers will soon be offering some of the unapproved peptides subject to the FDA's enforcement discretion policy to its customers.
FDA orders blindness risk warning to GLP-1 agonist labels
FDA has ordered all GLP-1 receptor agonist manufacturers to add a warning to their product labels for a rare eye condition that can cause blindness.
Bayer bags FDA green light for stroke drug Sunharbo
Bayer gets FDA nod for first-in-class oral Factor XIa inhibitor Sunharbo, a potential blockbuster, for secondary stroke prevention.
Amazon puts $100m into global health drive
Amazon Web Services has committed $100m in AI and cloud technology capacity to support the building of health services for "underserved communities."
MHRA grants Innovation Passports to three novel drugs
The MHRA has awarded Innovation Passports to three drugs that could offer a step forwards in treating lung cancer, Huntington's, and Alzheimer's.
Sales & Marketing
Digital
Market Access
Oncology
Patients
R&D
Partner Content
PMi Awards 2026: innovation, connection and a changing indus...
One of the things I enjoyed most about this year’s PM Society PMi Awards was the sheer breadth of the community in the room.
LEAP HR: Life Sciences Europe
Europe’s Only Industry-Specific Meeting Advancing HR Excellence in Life Sciences
Rational Based Drug Design Summit Europe
Driving Safer, Faster & More Efficient Discovery Across Europe
Evolution Summit 2027 to Convene Senior Clinical Development...
Westlake Village, CA: Marcus Evans today announced the Evolution Summit 2027, an invitation-only gathering of senior clinical trial executives
ISMAI 2026: Florence to host international symposium on the ...
On 3 and 4 December, in the CTO Auditorium of Careggi University Hospital, clinicians, scientists and international experts will discuss clinical judgement, patient safety and professional acco